A randomised, double-blind, placebo-controlled, cross-over pilot study using nabilone for symptomatic relief in patients with Huntington's disease
Latest Information Update: 23 Oct 2018
At a glance
- Drugs Nabilone (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 07 Sep 2006 New trial record.